These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31071384)

  • 1. Antipsychotic Use Among Youth in Foster Care Enrolled in a Specialized Managed Care Organization Intervention.
    Mackie TI; Cook S; Crystal S; Olfson M; Akincigil A
    J Am Acad Child Adolesc Psychiatry; 2020 Jan; 59(1):166-176.e3. PubMed ID: 31071384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foster care, externalizing disorders, and antipsychotic use among Medicaid-enrolled youths.
    Vanderwerker L; Akincigil A; Olfson M; Gerhard T; Neese-Todd S; Crystal S
    Psychiatr Serv; 2014 Oct; 65(10):1281-4. PubMed ID: 25124057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Medicaid Antipsychotic Medication Measures Among Children with SSI, Foster Care, and Income-Based Aid.
    Leckman-Westin E; Finnerty M; Scholle SH; Pritam R; Layman D; Kealey E; Byron S; Morden E; Bilder S; Neese-Todd S; Horwitz S; Hoagwood K; Crystal S
    J Manag Care Spec Pharm; 2018 Mar; 24(3):238-246. PubMed ID: 29485947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent mental health therapy among medicaid-enrolled youths starting antipsychotic medications.
    Harris E; Sorbero M; Kogan JN; Schuster J; Stein BD
    Psychiatr Serv; 2012 Apr; 63(4):351-6. PubMed ID: 22337007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic treatment among youth in foster care.
    Dosreis S; Yoon Y; Rubin DM; Riddle MA; Noll E; Rothbard A
    Pediatrics; 2011 Dec; 128(6):e1459-66. PubMed ID: 22106072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
    Sultan RS; Wang S; Crystal S; Olfson M
    JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-generation antipsychotic use among stimulant-using children, by organization of medicaid mental health.
    Saloner B; Matone M; Kreider AR; Budeir MS; Miller D; Huang YS; Raghavan R; French B; Rubin D
    Psychiatr Serv; 2014 Dec; 65(12):1458-64. PubMed ID: 25179737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade.
    Zito JM; Burcu M; Ibe A; Safer DJ; Magder LS
    Psychiatr Serv; 2013 Mar; 64(3):223-9. PubMed ID: 23242390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic Medication Prescribing: Youth in Foster Care Compared with Other Medicaid Enrollees.
    Keefe RJ; Cummings ADL; Smith AE; Greeley CS; Van Horne BS
    J Child Adolesc Psychopharmacol; 2023 May; 33(4):149-155. PubMed ID: 37204275
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in antipsychotic medication use after implementation of a Medicaid mental health carve-out in the US.
    Robst J
    Pharmacoeconomics; 2012 May; 30(5):387-96. PubMed ID: 22316397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of a State Medicaid Peer-Review Authorization Program on Pediatric Use of Antipsychotic Medications.
    Pennap D; Burcu M; Safer DJ; Zito JM
    Psychiatr Serv; 2018 Mar; 69(3):293-299. PubMed ID: 29137557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications.
    Burcu M; Zito JM; Ibe A; Safer DJ
    J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):112-9. PubMed ID: 24690011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities for Pharmacogenetic Testing to Guide Dosing of Medications in Youths With Medicaid.
    Tang Girdwood S; Hall M; Antoon JW; Kyler KE; Williams DJ; Shah SS; Orth LE; Goldman J; Feinstein JA; Ramsey LB
    JAMA Netw Open; 2024 Feb; 7(2):e2355707. PubMed ID: 38349656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal treatment for ADHD among youths in three Medicaid subgroups: disabled, foster care, and low income.
    dosReis S; Owens PL; Puccia KB; Leaf PJ
    Psychiatr Serv; 2004 Sep; 55(9):1041-8. PubMed ID: 15345765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in antipsychotic prescribing for approved and unapproved indications to Medicaid-enrolled youth in Philadelphia, Pennsylvania between 2014 and 2018.
    Candon M; Shen S; Fadeyibi O; Smith JL; Rothbard A
    BMC Psychiatry; 2021 Oct; 21(1):524. PubMed ID: 34686159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic medication prescribing in children enrolled in Medicaid.
    Rettew DC; Greenblatt J; Kamon J; Neal D; Harder V; Wasserman R; Berry P; MacLean CD; Hogue N; McMains W
    Pediatrics; 2015 Apr; 135(4):658-65. PubMed ID: 25733747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program.
    Patel NC; Crismon ML; Hoagwood K; Johnsrud MT; Rascati KL; Wilson JP
    Med Care; 2006 Jan; 44(1):87-90. PubMed ID: 16365617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth.
    Edelsohn GA; Karpov I; Parthasarathy M; Hutchison SL; Castelnovo K; Ghuman J; Schuster JM
    J Am Acad Child Adolesc Psychiatry; 2017 Jan; 56(1):59-66. PubMed ID: 27993230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Growth Of Antipsychotic Prescriptions For Children Who Are Publicly Insured Has Ceased, But Concerns Remain.
    Crystal S; Mackie T; Fenton MC; Amin S; Neese-Todd S; Olfson M; Bilder S
    Health Aff (Millwood); 2016 Jun; 35(6):974-82. PubMed ID: 27269012
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.